Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.04.2013 | Preclinical Study

The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding

verfasst von: Olga P. Rogozina, Katai J. Nkhata, Emily J. Nagle, Joseph P. Grande, Margot P. Cleary

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Previously we reported that intermittent calorie restriction (ICR) provided greater prevention of mammary tumors (MTs) than chronic calorie restriction (CCR). Here the impact of increased fat intake during refeeding in an ICR protocol was evaluated. MMTV-TGF-α female mice were assigned to one of three groups: ad libitum (AL) fed (n = 45) with free access to a moderately high fat diet (22 % fat calories); ICR (n = 45) 50 % calorie restricted for 3-week intervals followed by 3 weeks of 100 % of AL intake; and CCR (n = 45) fed 75 % of AL mice, matching each 6-week cycle of ICR mice. ICR mice were further designated as ICR-Restricted or ICR-Refed for data obtained during these intervals. All mice consumed the same absolute amount of dietary fat. Mice were followed to assess MT incidence, body weight and serum IGF-1, IGFBP3, leptin and adiponectin levels until 79 (end of final 3-week restriction) or 82 (end of final 3-weeks refeeding) weeks of age. Age of MT detection was significantly extended for CCR (74 weeks) and ICR (82 weeks) mice, compared to 57.5 weeks for AL mice. MT incidence for AL, ICR and CCR mice was 66.7, 4.4, and 52.3 %, respectively. Mammary and fat pad weights were reduced significantly following 50 % calorie restriction in ICR-Restricted mice compared to AL, CCR and ICR-Refed mice. IGF-1 and leptin levels also tended to be reduced in ICR-Restricted mice over the course of the study while adiponectin was not compared to AL, CCR, and ICR-Refed mice. The adiponectin:leptin ratio was consistently higher following 50 % restriction in ICR-Restricted mice. There was no relationship of IGF-1, leptin, or adiponectin with the presence of MTs in any groups. Thus the manner in which calories are restricted impacts the protective effect of calorie restriction independently of high fat intake.
Literatur
1.
Zurück zum Zitat Harvie M, Howell A (2006) Energy balance adiposity and breast cancer—energy restriction strategies for breast cancer prevention. Obes Rev 7:33–47PubMedCrossRef Harvie M, Howell A (2006) Energy balance adiposity and breast cancer—energy restriction strategies for breast cancer prevention. Obes Rev 7:33–47PubMedCrossRef
2.
Zurück zum Zitat Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW (1989) Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49:4130–4134PubMed Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW (1989) Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49:4130–4134PubMed
3.
Zurück zum Zitat Klurfeld DM, Welch CB, Davis MJ, Kritchevsky D (1989) Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 119:286–291PubMed Klurfeld DM, Welch CB, Davis MJ, Kritchevsky D (1989) Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 119:286–291PubMed
4.
Zurück zum Zitat Klurfeld DM, Lloyd LM, Welch CB et al (1991) Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med 196:381–384PubMed Klurfeld DM, Lloyd LM, Welch CB et al (1991) Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med 196:381–384PubMed
5.
Zurück zum Zitat Fernandes G, Chandrasekar B, Troyer DA et al (1995) Dietary lipids and calorie restriction effect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 92:6494–6498PubMedCrossRef Fernandes G, Chandrasekar B, Troyer DA et al (1995) Dietary lipids and calorie restriction effect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 92:6494–6498PubMedCrossRef
6.
Zurück zum Zitat Zhu Z, Haegele AD, Thompson HJ (1997) Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18:1007–1012PubMedCrossRef Zhu Z, Haegele AD, Thompson HJ (1997) Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18:1007–1012PubMedCrossRef
7.
Zurück zum Zitat Dirx MJM, Zeegers MPA, Dagnelie PC et al (2003) Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106:766–770PubMedCrossRef Dirx MJM, Zeegers MPA, Dagnelie PC et al (2003) Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106:766–770PubMedCrossRef
8.
Zurück zum Zitat Bunk B, Zhu P, Klinga K et al (1992) Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer 65:845–851PubMedCrossRef Bunk B, Zhu P, Klinga K et al (1992) Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer 65:845–851PubMedCrossRef
9.
Zurück zum Zitat Beth M, Berger MR, Aksoy M, Schmahl D (1987) Comparison between the effects of dietary fat level and calorie intake on methlynitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer 39:737–744PubMedCrossRef Beth M, Berger MR, Aksoy M, Schmahl D (1987) Comparison between the effects of dietary fat level and calorie intake on methlynitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer 39:737–744PubMedCrossRef
10.
Zurück zum Zitat Klurfeld DM, Welch CB, Lloyd LM, Kritchevsky D (1989) Inhibition of DMBA-induced mammary tumorigenesis by caloric restriction in rats fed high-fat diets. Int J Cancer 43:922–925PubMedCrossRef Klurfeld DM, Welch CB, Lloyd LM, Kritchevsky D (1989) Inhibition of DMBA-induced mammary tumorigenesis by caloric restriction in rats fed high-fat diets. Int J Cancer 43:922–925PubMedCrossRef
11.
Zurück zum Zitat Welsch CW, House JL, Herr BL et al (1990) Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. J Natl Cancer Inst 82:1615–1620PubMedCrossRef Welsch CW, House JL, Herr BL et al (1990) Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. J Natl Cancer Inst 82:1615–1620PubMedCrossRef
12.
Zurück zum Zitat Boissonneault GA, Elson CE, Pariza MW (1986) Net energy effects of dietary fat on chemically induced mammary carcinogenesis in F344 rats. J Natl Cancer Inst 76:335–338PubMed Boissonneault GA, Elson CE, Pariza MW (1986) Net energy effects of dietary fat on chemically induced mammary carcinogenesis in F344 rats. J Natl Cancer Inst 76:335–338PubMed
13.
Zurück zum Zitat Welsch CW (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52:2040s–2048sPubMed Welsch CW (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52:2040s–2048sPubMed
14.
Zurück zum Zitat Cleary MP, Grande JP, Maihle NJ (2004) Effect of a high fat diet on body weight and mammary tumor latency in MMTV-TGF-α mice. Int J Obes 28:956–962CrossRef Cleary MP, Grande JP, Maihle NJ (2004) Effect of a high fat diet on body weight and mammary tumor latency in MMTV-TGF-α mice. Int J Obes 28:956–962CrossRef
15.
Zurück zum Zitat Engelman RW, Day NK, Good RA (1994) Calorie intake during mammary development influences cancer risk: lasting inhibition of C3H/HeOu mammary tumorigenesis by peripubertal calorie restriction. Cancer Res 54:5724–5730PubMed Engelman RW, Day NK, Good RA (1994) Calorie intake during mammary development influences cancer risk: lasting inhibition of C3H/HeOu mammary tumorigenesis by peripubertal calorie restriction. Cancer Res 54:5724–5730PubMed
16.
Zurück zum Zitat Chen R-F, Good RA, Engelman RW et al (1990) Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc Natl Acad Sci USA 87:2385–2389PubMedCrossRef Chen R-F, Good RA, Engelman RW et al (1990) Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc Natl Acad Sci USA 87:2385–2389PubMedCrossRef
17.
Zurück zum Zitat Carlson AJ, Hoelzel F (1946) Apparent prolongation of the life span of rats by intermittent fasting. J Nutr 31:363–375PubMed Carlson AJ, Hoelzel F (1946) Apparent prolongation of the life span of rats by intermittent fasting. J Nutr 31:363–375PubMed
18.
Zurück zum Zitat Harris SR, Brix AE, Broderson JR, Bunce OR (1995) Chronic energy restriction versus energy cycling and mammary tumor promotion. Proc Soc Exp Biol Med 209:231–236PubMed Harris SR, Brix AE, Broderson JR, Bunce OR (1995) Chronic energy restriction versus energy cycling and mammary tumor promotion. Proc Soc Exp Biol Med 209:231–236PubMed
19.
Zurück zum Zitat Tagliaferro AR, Ronan AM, Meeker LD et al (1996) Cyclic food restriction alters substrate utilization and abolishes protection from mammary carcinogenesis in female rats. J Nutr 126:1398–1405PubMed Tagliaferro AR, Ronan AM, Meeker LD et al (1996) Cyclic food restriction alters substrate utilization and abolishes protection from mammary carcinogenesis in female rats. J Nutr 126:1398–1405PubMed
20.
Zurück zum Zitat Cleary MP, Jacobson MK, Phillips FC et al (2002) Weight-cycling decreases incidence and increases latency of mammary tumor development to a greater extent than does chronic restriction in mouse mammary tumor virus-transforming growth factor-α female mice. Cancer Epidemiol Biomarkers Prev 11:836–843PubMed Cleary MP, Jacobson MK, Phillips FC et al (2002) Weight-cycling decreases incidence and increases latency of mammary tumor development to a greater extent than does chronic restriction in mouse mammary tumor virus-transforming growth factor-α female mice. Cancer Epidemiol Biomarkers Prev 11:836–843PubMed
21.
Zurück zum Zitat Cleary MP, Hu X, Grossmann ME et al (2007) Prevention of mammary tumorigenesis by intermittent caloric restriction, does caloric intake during refeeding modulate the response? Exp Biol Med. 232:70–80 Cleary MP, Hu X, Grossmann ME et al (2007) Prevention of mammary tumorigenesis by intermittent caloric restriction, does caloric intake during refeeding modulate the response? Exp Biol Med. 232:70–80
22.
Zurück zum Zitat Rogozina OP, Bonorden MJL, Grande JP, Cleary MP (2009) Serum insulin like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted and intermittent calorie-restricted MMTV-TGF-α mice. Cancer Prev Res 2:712–719CrossRef Rogozina OP, Bonorden MJL, Grande JP, Cleary MP (2009) Serum insulin like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted and intermittent calorie-restricted MMTV-TGF-α mice. Cancer Prev Res 2:712–719CrossRef
23.
Zurück zum Zitat Pape-Ansorge KA, Grande JP, Christensen TA et al (2002) Effect of moderate caloric restriction and/or weight-cycling on mammary tumor incidence and latency in MMTV-neu female mice. Nutr Cancer 44:161–168CrossRef Pape-Ansorge KA, Grande JP, Christensen TA et al (2002) Effect of moderate caloric restriction and/or weight-cycling on mammary tumor incidence and latency in MMTV-neu female mice. Nutr Cancer 44:161–168CrossRef
24.
Zurück zum Zitat Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114:71–83PubMedCrossRef Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114:71–83PubMedCrossRef
25.
Zurück zum Zitat Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206PubMedCrossRef Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206PubMedCrossRef
26.
Zurück zum Zitat Barb D, Pazaitou-Panayiotou K, Mantzoros CS (2006) Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs 15:917–933PubMedCrossRef Barb D, Pazaitou-Panayiotou K, Mantzoros CS (2006) Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs 15:917–933PubMedCrossRef
27.
Zurück zum Zitat Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin- a growth factor for normal and malignant breast cells and normal mammary gland development. J Natl Cancer Inst 94:1704–1711PubMedCrossRef Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin- a growth factor for normal and malignant breast cells and normal mammary gland development. J Natl Cancer Inst 94:1704–1711PubMedCrossRef
28.
Zurück zum Zitat Laud K, Gourdou I, Pessemesse L et al (2002) Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188:219–226PubMedCrossRef Laud K, Gourdou I, Pessemesse L et al (2002) Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188:219–226PubMedCrossRef
29.
Zurück zum Zitat Dieudonne M-N, Machinal-Quelin F, Serazin-Leroy V et al (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293:622–628PubMedCrossRef Dieudonne M-N, Machinal-Quelin F, Serazin-Leroy V et al (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293:622–628PubMedCrossRef
30.
Zurück zum Zitat Ray A, Nkhata KJ, Cleary MP (2007) Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30:1499–1509PubMed Ray A, Nkhata KJ, Cleary MP (2007) Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30:1499–1509PubMed
31.
Zurück zum Zitat Garofalo C, Sisci D, Surmacz E (2004) Leptin interferes with the effects of the antiestrogen ICI 182.780 in MCF-7 breast cancer cell lines. Clin Cancer Res 10:6466–6475PubMedCrossRef Garofalo C, Sisci D, Surmacz E (2004) Leptin interferes with the effects of the antiestrogen ICI 182.780 in MCF-7 breast cancer cell lines. Clin Cancer Res 10:6466–6475PubMedCrossRef
32.
Zurück zum Zitat Dieudonne M-N, Bussiere M, Dos Santos E et al (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271–279PubMedCrossRef Dieudonne M-N, Bussiere M, Dos Santos E et al (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271–279PubMedCrossRef
33.
Zurück zum Zitat Grossmann ME, Nkhata KJ, Mizuno NK et al (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370–378PubMedCrossRef Grossmann ME, Nkhata KJ, Mizuno NK et al (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370–378PubMedCrossRef
34.
Zurück zum Zitat Takahata C, Miyoshi Y, Irahara N et al (2007) Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett 250:229–236PubMedCrossRef Takahata C, Miyoshi Y, Irahara N et al (2007) Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett 250:229–236PubMedCrossRef
35.
Zurück zum Zitat Körner A, Pazaitou-Panayiotou K, Kelesidis T et al (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041–1048PubMedCrossRef Körner A, Pazaitou-Panayiotou K, Kelesidis T et al (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041–1048PubMedCrossRef
36.
Zurück zum Zitat Chen D-C, Chung Y-F, Yeh Y-T et al (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109–114PubMedCrossRef Chen D-C, Chung Y-F, Yeh Y-T et al (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109–114PubMedCrossRef
37.
Zurück zum Zitat Mantzoros C, Petridou E, Dessypris N et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102–1107PubMedCrossRef Mantzoros C, Petridou E, Dessypris N et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102–1107PubMedCrossRef
38.
Zurück zum Zitat Grossmann ME, Ray A, Dogan S et al (2008) Balance of adiponectin and leptin in relationship to breast cancer cell growth. Cell Res 18:1154–1156PubMedCrossRef Grossmann ME, Ray A, Dogan S et al (2008) Balance of adiponectin and leptin in relationship to breast cancer cell growth. Cell Res 18:1154–1156PubMedCrossRef
39.
Zurück zum Zitat Rogozina OP, Bonorden MJL, Seppanen C et al (2011) Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res 4:568–581CrossRef Rogozina OP, Bonorden MJL, Seppanen C et al (2011) Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res 4:568–581CrossRef
40.
Zurück zum Zitat Dogan S, Rogozina OP, Loshkin A et al (2010) Effects of chronic vs intermittent calorie restriction on mammary tumor incidence and serum adiponecin and leptin levels in MMTV-TGF-α mice at different ages. Oncol Lett 1:167–176PubMed Dogan S, Rogozina OP, Loshkin A et al (2010) Effects of chronic vs intermittent calorie restriction on mammary tumor incidence and serum adiponecin and leptin levels in MMTV-TGF-α mice at different ages. Oncol Lett 1:167–176PubMed
41.
Zurück zum Zitat Shankaraiah K, Halberg F, Yunis E, Watson LM (1984) Alternate-day feeding alters the circadian system, reduces breast cancer incidence and prolongs life. In: Halberg F, Reale L, Tarquini B (eds) Proceedings of II international symposium on chronobiologic approach to social medicine. Instituto Itaniano di Medicina Sociale, Rome, pp 633–648 Shankaraiah K, Halberg F, Yunis E, Watson LM (1984) Alternate-day feeding alters the circadian system, reduces breast cancer incidence and prolongs life. In: Halberg F, Reale L, Tarquini B (eds) Proceedings of II international symposium on chronobiologic approach to social medicine. Instituto Itaniano di Medicina Sociale, Rome, pp 633–648
42.
Zurück zum Zitat Shao R, Dao ML, Day NK, Good RA (1990) Dietary manipulation of mammary tumor development in adult C3H/Bi mice. Proc Soc Exp Biol Med 193:313–317PubMed Shao R, Dao ML, Day NK, Good RA (1990) Dietary manipulation of mammary tumor development in adult C3H/Bi mice. Proc Soc Exp Biol Med 193:313–317PubMed
43.
Zurück zum Zitat Buison AM, Pellizzon MA, Brogan KE et al (2005) Weight cycling did not increase tumor incidence in high fat-fed rats treated with a low-dose 7,12-dimethylbenzyl(1)anthracene. Nutr Res. 25:1097–1108CrossRef Buison AM, Pellizzon MA, Brogan KE et al (2005) Weight cycling did not increase tumor incidence in high fat-fed rats treated with a low-dose 7,12-dimethylbenzyl(1)anthracene. Nutr Res. 25:1097–1108CrossRef
44.
Zurück zum Zitat Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Intermittent caloric restriction delays tumor detection and increases survival in TRAMP mice. Nutr Cancer 61:265–275PubMedCrossRef Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Intermittent caloric restriction delays tumor detection and increases survival in TRAMP mice. Nutr Cancer 61:265–275PubMedCrossRef
45.
Zurück zum Zitat Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Cross-sectional analyses of intermittent versus chronic caloric restriction in the TRAMP mouse. Prostate 69:317–326PubMedCrossRef Bonorden MJL, Rogozina OP, Kluczny CM et al (2009) Cross-sectional analyses of intermittent versus chronic caloric restriction in the TRAMP mouse. Prostate 69:317–326PubMedCrossRef
46.
Zurück zum Zitat Buschemeyer WC III, Klink JC, Mavropoulos JC et al (2010) Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice. Prostate 70:1037–1043PubMedCrossRef Buschemeyer WC III, Klink JC, Mavropoulos JC et al (2010) Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice. Prostate 70:1037–1043PubMedCrossRef
47.
Zurück zum Zitat Descamps O, Riondel J, Ducros V, Rousell A-M (2005) Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech Age Dev 126:1185–1191CrossRef Descamps O, Riondel J, Ducros V, Rousell A-M (2005) Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech Age Dev 126:1185–1191CrossRef
48.
Zurück zum Zitat Berrigan D, Perkins SN, Haines DC, Hursting SD (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23:817–822PubMedCrossRef Berrigan D, Perkins SN, Haines DC, Hursting SD (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23:817–822PubMedCrossRef
49.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Egan KM et al (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533–542PubMedCrossRef Trentham-Dietz A, Newcomb PA, Egan KM et al (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533–542PubMedCrossRef
50.
Zurück zum Zitat Mellemkjaer L, Emborg C, Gridley G et al (2001) Anorexia nervosa and cancer risk. Cancer Causes Control 12:173–177PubMedCrossRef Mellemkjaer L, Emborg C, Gridley G et al (2001) Anorexia nervosa and cancer risk. Cancer Causes Control 12:173–177PubMedCrossRef
51.
Zurück zum Zitat Michels KB, Ekbom A (2004) Caloric restriction and incidence of breast cancer. JAMA 291:1226–1230PubMedCrossRef Michels KB, Ekbom A (2004) Caloric restriction and incidence of breast cancer. JAMA 291:1226–1230PubMedCrossRef
52.
Zurück zum Zitat Harvie MN, Pegington M, Mattson MP et al (2011) The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes 35:714–727CrossRef Harvie MN, Pegington M, Mattson MP et al (2011) The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes 35:714–727CrossRef
53.
Zurück zum Zitat Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMedCrossRef Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMedCrossRef
54.
Zurück zum Zitat Peyrat JP, Bonneterre J, Hecquet B et al (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492–497PubMedCrossRef Peyrat JP, Bonneterre J, Hecquet B et al (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492–497PubMedCrossRef
55.
Zurück zum Zitat Yu H, Jin F, Shu X-O et al (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11:705–712PubMed Yu H, Jin F, Shu X-O et al (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11:705–712PubMed
56.
Zurück zum Zitat de Ostrovich KK, Lambertz I, Colgy JKL et al (2008) Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol 173:824–834PubMedCrossRef de Ostrovich KK, Lambertz I, Colgy JKL et al (2008) Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol 173:824–834PubMedCrossRef
57.
Zurück zum Zitat Hadsell DL, Bonnette SG (2000) IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 5:19–30PubMedCrossRef Hadsell DL, Bonnette SG (2000) IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 5:19–30PubMedCrossRef
58.
Zurück zum Zitat Dunn SE, Kari FW, French JE et al (1997) Dietary restriction reduces insulin-like growth-like factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667–4672PubMed Dunn SE, Kari FW, French JE et al (1997) Dietary restriction reduces insulin-like growth-like factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667–4672PubMed
59.
Zurück zum Zitat Powolny AA, Wang S, Carlton PS et al (2008) Interrelationships between dietary restriction, the IGF-I axiz, and expression of vascular endothelial growth factor by prostate adenocarcinomas in rats. Mol Carcinog 47:458–465PubMedCrossRef Powolny AA, Wang S, Carlton PS et al (2008) Interrelationships between dietary restriction, the IGF-I axiz, and expression of vascular endothelial growth factor by prostate adenocarcinomas in rats. Mol Carcinog 47:458–465PubMedCrossRef
60.
Zurück zum Zitat Cleary MP, Ray A, Rogozina OP et al (2009) Targeting the adiponectin-leptin ratio for prevention of postmenopausal breast cancer. Front Biosci 1:329–357 Cleary MP, Ray A, Rogozina OP et al (2009) Targeting the adiponectin-leptin ratio for prevention of postmenopausal breast cancer. Front Biosci 1:329–357
61.
Zurück zum Zitat Petridou E, Mantzoros C, Dessypris N et al (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993–997PubMedCrossRef Petridou E, Mantzoros C, Dessypris N et al (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993–997PubMedCrossRef
62.
Zurück zum Zitat Tworoger SS, Eliassen AH, Kelesidis T et al (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510–1516PubMedCrossRef Tworoger SS, Eliassen AH, Kelesidis T et al (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510–1516PubMedCrossRef
63.
Zurück zum Zitat Nkhata KJ, Ray A, Schuster TF et al (2009) Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 21:1611–1619PubMed Nkhata KJ, Ray A, Schuster TF et al (2009) Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 21:1611–1619PubMed
Metadaten
Titel
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding
verfasst von
Olga P. Rogozina
Katai J. Nkhata
Emily J. Nagle
Joseph P. Grande
Margot P. Cleary
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2464-7

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.